Document:

Exhibit
10.1

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

Statement
of Work No. 3

 

This
Statement of Work No. 3 (“SOW No. 3”), dated August 1, 2021 (“Effective Date”), replaces the Statement
of Work No. 2 by and between IDS Infotech Limited (“Service Provider”) and Augmedix Operating Corp. f/k/a
Augmedix, Inc. (“Augmedix”), dated June 1, 2020 (“SOW No. 2”). This SOW No. 3 is entered into
by the Parties pursuant to that certain Master Services Agreement, dated October 1, 2019 (the “Agreement”), and this
SOW No. 3 is hereby incorporated into the Agreement by this reference.

 

All
capitalized terms used in this SOW No. 3 shall have the meanings given to them in this SOW No. 3 (including those defined in Appendix
A, B, C, and D attached hereto and herein incorporated by this reference, and in any other appendix attached
hereto), provided that capitalized terms used in this SOW No. 3 but not otherwise defined herein shall have the meanings given to them
in the Agreement. In the event of a conflict between the terms and conditions of this SOW No. 3 and the Agreement, the terms and conditions
of this SOW No. 3 shall prevail. For the purposes of this SOW No. 3, the Parties’ notice addresses shall be as described in the
Agreement.

 

		I.	TERMINATION
                                            OF STATEMENT OF WORK NO. 2

 

As
of the Effective Date, SOW No. 2 is hereby terminated and replaced by this SOW No. 3. All active purchase orders entered under SOW No.
2 shall be, as of the Effective Date, subject to the terms and conditions of this SOW No. 3.

 

		II.	TERM

 

The
initial term of this SOW No. 3 (the “Initial Term”) shall begin on the Effective Date and it shall expire twelve (12)
months thereafter, provided that the term of this SOW No. 3 shall automatically be extended for successive twelve (12) month periods
(each a “Renewal Term”, with the “Initial Term” and all “Renewal Term(s)” collectively
referred to as the “Term”), unless either Party has given the other Party written notice of termination at least three
(3) months prior to the expiration of the then-current Term. Notwithstanding the foregoing, either Party may terminate this SOW No. 3
without penalty at any time by giving the other Party written notice no less than three (3) months before such termination is to take
effect.

 

		III.	SERVICES

 

In
consideration of Augmedix’s compliance with the terms and conditions of the Agreement and this SOW No. 3 (including Augmedix’s
timely payment of the fees described later in this SOW No. 3), Service Provider shall provide Augmedix with the remote medical documentation
and clinical support services described below (the “Services”). Notwithstanding anything to the contrary in this SOW
No. 3, Service Provider will at all times ensure that its provision of the Services complies with all Augmedix requirements and policies
and procedures applicable to performance under the Agreement and this SOW No. 3, including, but not limited to, Service Provider’s
obligations described in: (i) the Operational Requirements for Scribe Vendors (“ORSV”), which Service Provider acknowledges
having received from Augmedix, (ii) the requirements and benchmarks contained in the Training and Performance SLA and the Technology
SLA attached hereto as Appendix B and Appendix C, respectively, (iii) the Medicare Advantage Addendum attached hereto as
Appendix D, and (iv) the applicable Business Associate Agreement between Augmedix and Service Provider.

 

		1.	Recruiting

 

		a.	Each
                                            Trainee must pass (i) the applicable Augmedix screening assessment, as may be modified by
                                            Augmedix from time to time, at or above the minimum score stipulated by Augmedix, or (ii)
                                            a comparable screening process mutually agreed between Augmedix and Service Provider.
	 	 	 
		b.	Service
                                            Provider will make best efforts to recruit a sufficient number of Trainees to provide Augmedix
                                            with Scribing Services for the number of Scribes reflected in the applicable Augmedix Forecast.
	 	 	 
		c.	Service
                                            Provider will provide Augmedix with monthly updates on: (i) Service Provider’s ability
                                            to deliver the Scribing Services to the number of Users specified in the Forecast; and (ii)
                                            Service Provider’s estimate of how many additional Users for which it could provide
                                            Scribing Services.

 

    	Service Provider SOW No. 3	Page 1 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

		2.	Augmedix
Scribe Training (“AST”)

 

		a.	Each
                                            Trainee must pass the Doctor-Ready Assessment (as defined in Appendix A), as may be
                                            modified and/or revised by Augmedix from time to time.
	 	 	 
		b.	Service
                                            Provider will, at its expense, train Trainees to pass the Doctor-Ready Assessment.
	 	 	 
		c.	Augmedix
                                            will provide Service Provider with a proposed Scribe training curriculum for the Service
                                            Provider to use in training Trainees. Notwithstanding, Service Provider is permitted and
                                            encouraged to develop additional training plans and materials for its Trainees.
	 	 	 
		d.	Service
                                            Provider is responsible for scheduling the final DR test, as further described in the Doctor-Ready
                                            Assessment, when it deems a class of Trainees are ready. Either Augmedix or Service Provider,
                                            at Augmedix’s direction, will conduct the DR test for the Trainees and provide notice
                                            of the results of the Doctor-Ready Assessment. Notwithstanding, all Doctor-Ready Assessments
                                            are subject to final approval by Augmedix.
	 	 	 
		e.	Each
                                            Trainee that passes the Doctor-Ready Assessment is deemed to have graduated from the Augmedix
                                            Scribe training program and either transitions to specialty training, if applicable, or assignment
                                            on a Provider.
	 	 	 
		f.	Augmedix’s
                                            criteria for passing the Doctor-Ready Assessment are subject to change in the manner described
                                            in the Change Management Process (as described in Section V of the Agreement).

 

		3.	Assignment
and Specialty Training

 

		a.	Augmedix
                                            will, in conjunction with Service Provider, determine assignment of each DR Scribe to a User,
                                            subject to final approval by Augmedix, and if appliable, schedule such Scribe to take the
                                            appropriate specialty training.
	 	 	 
		b.	Augmedix,
                                            or the Service Provider upon Augmedix’s written consent, will provide a proposed specialty
                                            training plan for DR Scribes, if applicable.

 

		4.	In-Service

 

		a.	Once
                                            a Scribe has completed his or her specialty training (if applicable), the Scribe is permitted
                                            to begin drafting Notes and Charts for his or her assigned User. A Scribe is “in service”
                                            when such Scribe consistently produces one or more Charts meeting Augmedix’s minimum
                                            standards (as communicated by Augmedix and updated from time to time) for his or her assigned
                                            User.
	 	 	 
		b.	Service
                                            Provider is responsible for scheduling a DA Audit or submitting a specialty approval checklist
                                            when it deems a Scribe to be consistently producing 100% of a User’s Charts meeting
                                            Augmedix standards for his or her assigned User’s scheduled shifts.
	 	 	 
		c.	The
                                            Service Provider will make best efforts to ensure that Scribes that are assigned to a ramp
                                            up for a new User or transition to an existing User progress according to a schedule and
                                            benchmarks set by Augmedix. A Scribe that fails to progress according to the schedule and
                                            meet the associated benchmarks shall, at Augmedix’s sole discretion, be:

 

		1)	Required
                                            to complete a performance improvement plan provided by Augmedix (“PIP”);
	 	 	 
		2)	Removed
                                            from the assigned User, and be available for assignment on a different User; or

 

		3)	Permanently
                                            removed from providing services to Augmedix if such Scribe fails a DA Audit or is removed
                                            from an Account as a result of a User’s concerns.

 

		d.	Service
                                            Provider will ensure that Scribes draft Charts for all assigned patient visits of an assigned
                                            User’s scheduled shift (or, if applicable, for their assigned portion of such working
                                            day).
	 	 	 

		e.	Performance
                                            Specialists, who shall be employees of Service Provider, must perform checkpoint and DA audits
                                            at scribe ramp up milestones that demonstrate scribe readiness to work independently. At
                                            these checkpoints, the PS must provide a clinician tier and approve target scope:stream time.

 

    	Service Provider SOW No. 3	Page 2 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

		f.	Performance
                                            Specialists must randomly perform quarterly redline comparisons on each scribe’s Notes
                                            to ensure compliance with the minimum standards set forth in the Augmedix Redline Comparison
                                            Rubric. If a redline comparison falls below the minimum standards, the PS must audit Charts
                                            produced by Scribes, and such audits must demonstrate that the Scribe is meeting Augmedix’s
                                            quality and time to complete standards. Service Provider may be required to, at Augmedix’s
                                            sole discretion, remove a Scribe from a User and/or require a Scribe to complete a PIP if:
	 	 	 

		1)	A
                                            Scribe’s Chart scores fall below minimum standards set by Augmedix; or
	 	 	 

		2)	There
                                            is a User complaint regarding Scribe’s Chart quality.
	 	 	 

		g.	Scribes
                                            must complete any applicable PIPs described above according to a schedule and benchmarks
                                            agreed between Service Provider and Augmedix. Service Provider shall notify Augmedix upon
                                            completion of any PIP. Augmedix may, in its sole discretion, perform an audit to confirm
                                            a Scribe has successfully fulfilled his or her PIP.

 

		5.	Scheduling
of all Scribes

 

		a.	Service
                                            Provider shall create and assign schedules for all its Scribes based on their User schedules
                                            (which Service Provider shall obtain from each such User’s EHR) or as otherwise agreed
                                            with Augmedix. Service Provider will ensure 100% coverage for all its assigned Users’
                                            clinic schedules (each a “User Shift Schedule”) by Augmedix approved Scribes.
	 	 	 

		b.	Augmedix
                                            shall create and assign schedules for each PS based on his or her Account assignments.
	 	 	 

		c.	Service
                                            Provider shall upload into the Augmedix scheduling tool at least fourteen (14) days in advance:
                                            (i) User Shift Schedules; and (ii) Scribes and PSs work schedules for a given week (including
                                            all working hours categorized by type of work, such as Chart prep time, Chart editing time,
                                            grading etc.). Service Provider shall monitor the schedules of the Users and update such
                                            schedules daily (including modifying the applicable Scribes’ schedules) in the Augmedix
                                            scheduling tool.

 

		d.	Scribes
                                            should be online at least fifteen (15) minutes prior to the scheduled time for Users’
                                            shifts. Where applicable on a User-by-User basis, Augmedix will determine and inform Service
                                            Provider if additional time is required from the Scribe to complete the Charts for his or
                                            her assigned User within a given workday.

 

    	Service Provider SOW No. 3	Page 3 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

		IV.	FEES
                                            AND PAYMENTS

 

		1.	Forecasting
	 	 	 

		a.	Augmedix
                                            shall deliver to Service Provider a monthly forecast setting forth the estimated number of
                                            new users it will need to Service Provider to service each month (“Forecast”).
                                            Service Provider shall use the Forecast to assess its staffing needs and to ensure it is
                                            able to service its assigned Users. Augmedix will use commercially reasonable efforts to
                                            adhere to its Forecast, but such Forecast is subject to modification.
	 	 	 

		2.	Monthly
                                            Invoicing
	 	 	 

		a.	No
                                            later than [***] after the end of a given month, Service Provider will provide Augmedix with
                                            an invoice for Services rendered to Augmedix in the prior month in conformance with the compensation
                                            terms set forth in Section IV.3 below. Augmedix shall pay each such undisputed invoice within
                                            [***] of receipt.
	 	 	 

		b.	Service
                                            Provider will comply with any Augmedix requests for Service Provider’s invoice to follow
                                            Augmedix’s preferred format if Augmedix provides Service Provider with a template for
                                            such invoice.
	 	 	 

		3.	Compensation

 

		a.	Monthly
                                            Fees. 

 

		1.	Augmedix
                                            Live. Each calendar month during the term, Augmedix will pay Service Provider an hourly
                                            rate of US$[***] per Scribe Contracted Hour of each Augmedix Live In-Service User during
                                            the prior calendar month (which shall be prorated for partial months of service). For clarity,
                                            an Augmedix Live In-Service User is considered “In-Service” as of the first day
                                            a Scribe begins producing one or more Charts for all or part of a User’s scheduled
                                            shift.

 

		a.	Augmedix
                                            must pre-approve (i) all staffing by Service Provider of more than one Scribe working simultaneously
                                            on a User, for all or part of such User’s clinical shifts (“Increased Staffing”),
                                            and (ii) the number of Increased Staffing hours necessary to service such User. Augmedix
                                            will pay US$[***] for each agreed Increased Staffing Hour per User.

 

		2.	[Intentionally
                                            omitted].

 

		b.	The
                                            compensation described in this Section is subject to offsets based on the credits described
                                            in the Scribe Training and Performance SLA and Augmedix Technology SLA attached hereto as
                                            Appendix B, and Appendix C, respectively. 

 

    	Service Provider SOW No. 3	Page 4 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

		c.	Performance
                                            Specialists. Each calendar month during the Term, Augmedix will pay Service Provider
                                            a flat fee of US$[***] per month (prorated for partial months) for each full-time Performance
                                            Specialist who provides training and feedback to Scribes during the prior calendar month,
                                            provided that the PS is requested and approved by Augmedix. For the avoidance of doubt, to
                                            the extent an approved PS works as both a Scribe and PS during a particular month, PS compensation
                                            shall be prorated for the time period during which such individual serves as a PS.

 

		V.	Change
                                            Management Process

 

Any
changes to the procedures and production related processes in this SOW No. 3 (each a “Change”) shall follow the process
described in this Section (the “Change Management Process”). A Change must be proposed in writing by one party to
the other party at least two (2) weeks in advance of the date the proposing party desires for such Change to take effect. The parties
will confer on such proposed Change until the parties reach mutual agreement in writing as to the nature and effective date of such Change,
provided that Augmedix shall have the sole discretion to accept or reject a proposed Change if the parties cannot reach mutual agreement
on the nature and timing of such Change within two (2) weeks of the Change first being proposed. For the avoidance of doubt, if Augmedix
proposes a Change using the above process and Service Provider does not respond to such Change within two (2) weeks, then the Change
is deemed accepted by Service Provider.

 

This
SOW No. 3 is hereby executed by the authorized representatives of Service Provider and Augmedix as of the Effective Date, notwithstanding
the actual dates of the parties’ signatures hereon:

 

	 	IDS Infotech Limited   	 	 	Augmedix Operating Corp.  
	 	 	 	 	 
	By	/s/ Deepak Mahajan	 	By	/s/ Sandra Breber
	Name 	Deepak
Mahajan	 	Name 	Sandra
Breber
	Title	CFO	 	Title	 COO
	Date	8/10/21	 	Date	8/10/21

 

    	Service Provider SOW No. 3	Page 5 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

Appendix
A

 

Defined
Terms for SOW No. 3

 

“Account”
means an Augmedix customer that has contracted with Augmedix to create Charts, and such customer may be a User, in the case of independent
doctors, or a small clinic or a large health system.

 

“Augmedix
Grading Rubric” means the criteria used by Augmedix for grading and scoring of Notes and Charts in connection with the Doctor-Approval
Audit and steady-state Scribing.

 

“Augmedix
Live” means the real-time documentation solution provided by Augmedix, which such solution includes remote, real-time Scribing
by Scribe(s) for User(s).

 

“Augmedix
Notes” means the non-real time documentation solution provided by Augmedix, which such solution includes Scribing by remote
Scribe(s) for User(s) from recordings of patient-User encounters.

 

“Chart(s)”
means a complete draft Note of a patient encounter uploaded onto an Account’s EHR.

 

“Doctor-Approval
Audit” or “DA Audit” means the audit that Augmedix uses to assess a Scribe’s ability to draft a 100% of his
or her assigned User’s Charts meeting Augmedix’s quality standards for each scheduled shift.

 

“Doctor-Ready
Assessment” or “DR Assessment” means the assessment criteria that Augmedix uses to assess the Trainee’s readiness
for transition to specialty training, if applicable, or assignment on a User, and thereby, become a DR Scribe.

 

“EHR”
means an electronic health record system, a.k.a. the EMR or Electronic Medical Record.

 

“Go-Live
Date” means the first day on which Service Provider produces one or more Charts for an assigned User.

 

“In-Service
User” means a User for whom a Scribe has begun drafting one or more Charts meeting Augmedix quality standards for all or part
of his or her scheduled shift.

 

“Notes”
means notes of patient encounters completed in a document other than an Account’s EHR.

 

“DR
Scribe” means a Trainee who has passed the Doctor-Ready Assessment and has been approved by Augmedix for transition to specialty
training, if applicable, or direct assignment to a User.

 

“User”
means a doctor, a nurse practitioner or a physician’s assistant that works either directly or indirectly for an Account.

 

“Scribe”
means an unlicensed individual hired to enter, edit or retrieve information in an EHR at the direction of a User.

 

“Scribing”
means a Scribe’s act of entering, editing, and/or retrieving content in an Account’s EHR, and providing other clinical support,
at the direction of a User based upon a User-clinician encounter.

 

“Scribe
Contracted Hour” means an hour of Scribe services contracted by a User and charged by Augmedix pursuant to an Account agreement.
For the avoidance of doubt, in the event an Augmedix contract with an Account is defined in contracted doctor hours (i.e., a User’s
scheduled clinic hours), Augmedix will convert such contracted doctor hours into Scribe Contracted Hours.

 

“Trainee”
means an individual recruited by the Service Provider who is going through the Augmedix Scribe training program.

 

“Performance
Specialist” or “PS” means an individual that Augmedix has approved to provide grades and feedback on Notes and
Charts to Scribes.

 

    	Service Provider SOW No. 3	Page 6 of 13

     

    

 

CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE
COMPETITIVE HARM TO AUGMEDIX, INC. IF PUBLICLY DISCLOSED.

 

Appendix
B

 

Augmedix
Training and Performance SLA

 

I.
Training

 

Augmedix
Scribe Training – Service Provider shall upload to an Augmedix-specified location all the Notes that the Trainee has completed
each day and the Service Provider must accurately document the number of Notes completed by the Trainee. Augmedix or Service Provider
will grade the Notes as specified in the Augmedix Scribe training program until Service Provider has trained its training program trainer
to perform such task.

 

Implementation
and Transition – Augmedix or Service Provider will provide grades and feedback for all Scribes in implementations and transitions
as stated in the respective implementation or transition training plan.

 

Final
Doctor Ready Test – Augmedix or Service Provider will [***] using the Augmedix Grading Rubric and the score of the Notes
will determine the result of the Trainee being audited.

 

Doctor
Approval Audit – Augmedix or Service Provider will [***] using the Augmedix Grading Rubric and the average score of those
Charts will determine the result of the DR Certified Scribe being audited. The Scribe must score an average of 45/50 on all Charts graded
during the audit to pass the DA Audit.

 

II.
Performance

 

Forecasting
– Service Provider will make best endeavors to ensure that the recruiting projections provided to Augmedix pursuant to
Section III.1.c of the SOW No. 3 are complete and accurate. Augmedix will review and audit Service Providers’ projections of its
ability to deliver on its forecasts.

 

Service
Availability – Service Provider must ensure that Scribes adhere to User Shift Schedules [***] of the time. For each failure
to provide the Scribing Services according to User Shift Schedules, Service Provider will provide a credit against its monthly invoice
to Augmedix for a given month as follows:

 

		1)	US$[***]
for each calendar day in any given month that a Scribe or an Augmedix-approved equivalent misses one or more Charts for a Provider due
to issues within the control of Service Provider (e.g., Scribe being absent or tardy, technical issues at the Service Provider site,
etc.).

 

		2)	US$[***]
for each time a Provider makes a complaint regarding the unavailability of a Scribe or an Augmedix-approved equivalent due to issues
within the control of a Service Provider (e.g., failure of Scribe to be on-line at least fifteen (15) minutes prior to a Provider’s
shift).

 

Quality
Standards – If a Scribe requires more than one performance improvement plan per year due to a Provider complaint, then
Augmedix may either remove (i) the Scribe from the Provider or Account, or (ii) the entire Account from the Service Provider.

 

III.
Termination of Access

 

Service
Provider shall notify Augmedix immediately, but in no event later than twenty-four (24) hours, after a Service Provider employee, who
has access to Account Protected Health Information, is terminated.

 

    	Service Provider SOW No. 3	Page 7 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

Appendix C

 

SERVICE PROVIDER TECHNOLOGY SLA

Updated April 2019

 

	1.	Goals and Objectives

 

The purpose of this agreement is to
ensure that the proper expectations, requirements and commitments are in place for scribe vendors to provide consistent and reliable technology
infrastructure delivery and support for Augmedix’s enterprise-class business. The commitment to reliability is essential because
Provider-Scribe downtime negatively, and often severely, impact Augmedix’s business. The key objectives of this agreement are to
provide a clear reference to service ownership, support, roles and/or responsibilities, and present a measurable description of the service
provisioning, expectations for service reporting and articulate incentives and penalties for service-level guarantees.

 

	2.	Periodic Review and Updates

 

Augmedix owns this document and is responsible
for facilitating regular reviews. The contents of this document may be amended as required, provided mutual agreement is obtained from
the primary stakeholders and communicated to all affected parties. The document owner will incorporate all subsequent revisions and obtain
mutual agreements/approvals as required. This agreement will be made accessible to all stakeholders as required. The recommended review
period is quarterly but changes to this document will necessitate an immediate review and approval.

 

	3.	In-Scope Services

 

This agreement covers all infrastructure
services provided by the Service Provider and leveraged by the scribe operations including network, access, systems, hardware, software/applications,
security, user management etc. This includes the Internet Service Providers (ISP) and third-party vendors that the Service Provider relies
upon for delivery and support of the scribe operations.

 

	4.	Service Level Guarantees

 

	 	●	[***]% service uptime (during scribing operational hours, i.e., from the time when the first scribe logs in to the time the last scribe logs out)

 

	 	●	Service uptime will be reviewed on a monthly basis.

 

	 	●	The requirements and benchmarks set forth herein are subject to change under the Change Management Process outlined in Section V of the SOW.

 

    	Service Provider SOW No. 3	Page 8 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

	5.	Service Expectations and Requirements

 

It is expected that the Service Provider
will take a proactive approach to supporting Augmedix and will provide the highest level of customer service and technical support. Both
robust service and technology go hand-in-hand and are fundamental requirements for the Augmedix service.

 

5.1 Proactive Notifications

 

Augmedix expects to be notified proactively, per
the priority definitions, in the event of any network and/or system issues that impact Scribe operations including planned downtime (maintenance).

 

5.2 Technical Expertise

 

Augmedix expects Service Provider’s technical/IT
team to have superior technical expertise in network and system configuration, design, maintenance and troubleshooting as well as application
installation, maintenance, and upgrades. Competency in both hardware and software is required.

 

5.3 Training

 

It is the responsibility of Service Provider to
train its technical/IT staff on the tools, technologies and processes required for the support of the Augmedix service and scribe operations.

 

5.4 Documentation

 

All infrastructure and system specifications,
configurations and processes must be documented and made available to Augmedix. These documents must be reviewed with Augmedix once a
quarter.

 

5.5 Service Testing and Validation

 

In the event Augmedix needs support to validate
a new service/application, Service Provider must make resources available to validate and share the results within the shared/expected
timeline.

 

5.6 Monitoring Workstation Availability

 

Workstation monitoring must be conducted on a
24/7 basis. A notification must be triggered in the case of unavailability of the system. In such case, the system must be restored within
24 hours.

 

    	Service Provider SOW No. 3	Page 9 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

	6.	Service Change Management

 

Any
planned changes to the state of Augmedix’s production scribe services, including hardware, software, networks and facilities must
go through a process of change impact analysis, review and approval prior to implementation.  Each change must follow the Change
Management Process outlined in Section V of the SOW.

 

Any failure on the part of Service Provider to
follow the Change Management Process will be considered a “Breach of Process” for which Service Provider must provide proper
justification.  Augmedix may audit any changes to verify the requests.

 

	7.	Service Escalation Management

 

All
critical and high-priority incidents (defined below) resulting in the loss of service must immediately trigger the creation of
a war-room by the Service Provider and the involvement of the Service Provider and Augmedix technical teams to facilitate the discussion
of outstanding issues and satisfactory resolution and closure of the ticket(s):

 

	 	●	Interruption making a critical functionality inaccessible or a complete network interruption causing a severe impact on services availability.

 

	 	●	Critical functionality or network access interrupted, degraded or unusable, having a severe impact on services availability.

 

In
order to facilitate the management of escalated incidents, the Service Provider must provide to Augmedix a tiered Escalation Matrix
that must include the name of the individual, phone number, email, and conditions under which an incident will be escalated up the
management chain.

 

	8.	Service Security

 

Service
Provider is expected to make sure that critical network infrastructure, systems, applications and scribe operations have all the necessary
security controls in place for a safe and secure operating environment. Adherence to the compliance, security and privacy requirements
set forth in the Operational Requirements for Service Providers (“ORSV”) document is mandatory.

 

    	Service Provider SOW No. 3	Page 10 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

  

8.1 ORSV
Audits

 

Augmedix
or its designee shall have the right to audit, monitor, and verify Service Provider’s compliance with the ORSV. Augmedix
may perform two such audits per twelve (12) month period; provided, however, Augmedix may perform additional audits in response to
specific security or privacy incidents or identified gaps in compliance with the ORSV. Augmedix will bear the cost of two
planned audits per year. The cost of any additional audits conducted in response to specific security incidents, privacy incidents
or identified gaps in compliance will be borne by the Scribe Partner.

 

Should Augmedix determine in its sole discretion,
that Service Provider has failed to adhere to the requirements of the ORSV, Service Provider must successfully remediate any compliance
deficiencies to the satisfaction of Augmedix within (10) business days of written notice of such deficiencies.  If Service Provider
fails to remediate deficiencies within the time period prescribed above, or the deficiency is a repeat violation of the same ORSV requirement,
Service Provider shall provide Augmedix a credit against Service Provider’s monthly invoice for that month in the amount of up to
US$[***] (at Augmedix’s sole discretion) for each day that the deficiencies remain unresolved and/or repeat violations.  Further,
Augmedix, in its sole discretion, reserves the right to remove Service Provider from its existing Accounts, or withhold the assignment
of new Accounts to Scribe Partner until all deficiencies are resolved to the satisfaction of Augmedix.

 

	9.	Service Support Availability

 

Technical
support coverage must align with the Provider schedules that the Service Provider is servicing. Such schedules will be documented in a
Single Source of Truth (example: Humanity) for production service availability. In addition, Augmedix may require the availability
of the technical/IT support staff during maintenance and/or test windows. Such requests will be made at least 2 business days in
advance.

 

	10.	Service Maintenance and Outages

 

All
service maintenance must be performed during scheduled maintenance windows. These activities will render systems and/or applications unavailable
for scribe operations at the agreed-upon locations and for the defined time windows. The change management process applies to un-planning
service outages as well.  In addition, each service disruption/outage must be followed by a Root Cause Analysis/Post-Mortem Report
within [***] of resolution of the outage.  

 

In the event of an outage, Service Provider
must notify Augmedix within 5 minutes of such occurrence. Thereafter, Service Provider must provide an intermediate progress update to
Augmedix every 15 minutes until the issue is resolved.

 

	11.	Service Reporting

 

Augmedix
expects the Service Provider to present the following reports:

 

	 	1.	Service uptime (and downtime) – Monthly
	 	 	 
	 	2.	Service outages – Monthly
	 	 	 
	 	3.	Root Cause Analysis (RCA)/Post- Mortem Report – within 48 hours

 

    	Service Provider SOW No. 3	Page 11 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

	12.	Service Exceptions

 

Any
deviations from agreed upon policies and processes must be brought up in advance for review and approval in accordance with the defined
Change Management Process.

 

	13.	Service Incentives/Penalties

 

Should
Service Provider fail to meet the requirements and benchmarks set forth in this Technology SLA and the Scribe Operation Technology Requirements,
Augmedix in its sole discretion reserves the right to remove Service Provider from its existing Accounts or withhold the assignment of
new Accounts to Service Provider (even if Augmedix has purchased Scribing Services for a designated number of Users in the applicable
Purchase Orders) until all deficiencies are resolved to the satisfaction of Augmedix.

 

	14.	Priority Level Definitions

 

To
create clear expectations, Augmedix defines priority levels based on the criticality of its function.  The priority levels, including
resolution, response and update interval timelines are set forth in the table below:

 

	Priority	Name	Description	Resolution	First Response Time	Intermediate Update Interval
	P1	Critical	Interruption making a critical functionality inaccessible or a complete network interruption causing a severe impact on services availability.	1 hour or less	5 mins or less	15 mins
	P2	High	Critical functionality or network access interrupted, degraded or unusable, having a severe impact on services availability.	2 hours	15 mins or less	30 mins
	P3	Medium	Non critical function or procedure, unusable or hard to use, having an operational impact but with no direct impact on services availability.	8 hours	30 mins or less	4 hours
	P4	Low	Application or personal procedure unusable, where a workaround is available, or a repair is possible.	24 hours	1 hour or less	N/A
	P5	Request	General service request	48 hours	4 hours or less	N/A

 

Service Provider shall make every attempt to meet
the restoration targets listed above.  Incidents shall be deemed “restored” when Augmedix reasonably determines that
Service Provider has provided a suitable resolution, solution, or work-around for the incident.  Suitable shall mean that the resolution,
solution or work-around does not materially impact Augmedix ability to provide its Services.

 

	1. 	References

 

Augmedix Operational Requirements
for Scribe Vendors (ORSV)

Scribe Operations Technology
Requirements

Technology Best Practices
& Recommendations for Scribe Operations

Change Management Process
for Augmedix Operations

 

    	Service Provider SOW No. 3	Page 12 of 13

     

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

Appendix D

 

[Executed Medicare Advantage Addendum to be
inserted]

 

 

	Service Provider SOW No. 3	Page 13 of 13Exhibit 10.2

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

SECOND OMNIBUS AMENDMENT

 

This Second Omnibus Amendment
(“Second Omnibus Amendment”) is made and entered into as of July 1, 2021 (“Amendment Effective Date”),
by and between, on the one hand, Augmedix Operating Corp. f/k/a Augmedix, Inc. (“Augmedix”) and, on the other hand,
Dignity Health (“DH”), Dignity Health Medical Foundation (“DHMF”), and Pacific Central Coast Health
Centers (“PHC” and, together with the DH and DHMF, the “Client”), and amends:

 

		(1)	That certain Amended and Restated Statement of Work, dated January 24, 2019, as amended, by and between
DH and Augmedix (the “DH-SOW No. 1”); and

 

		(2)	That certain Statement of Work No. 2, dated March 2, 2020, as amended, by and between DH and Augmedix
(the “DH-SOW No. 2”); and

 

		(3)	That certain Statement of Work, dated July 3, 2016, as amended, by and between DHMF and Augmedix
(the “DHMF-SOW”); and

 

		(4)	That certain Statement of Work, dated January 26, 2016, as amended, by and between PHC and Augmedix
(the “PHC-SOW” and, together with the DH-SOW No. 1, DH-SOW No. 2, and DHMF-SOW, the “Dignity
SOW(s)”).

 

WHEREAS, Dignity Health (for
itself and on behalf of its affiliates) and Augmedix entered into that certain Services Agreement, dated September 1, 2015 (the “Agreement”).

 

NOW, THEREFORE, in consideration
of the mutual benefits and promises between the parties, the sufficiency of which each party hereby acknowledges, the Dignity SOWs are
hereby amended as follows:

 

1. Term.
Notwithstanding anything to the contrary in the Dignity SOWs, this Second Omnibus Amendment extends the Term of the Dignity SOWs through
and including June 30, 2022, unless earlier terminated in accordance with the Agreement.

 

2. Fees.
Notwithstanding anything to the contrary in the Dignity SOWs, Fees will be charged and assessed for authorized users as follows:

 

“For each
Authorized User, Client will be billed a base monthly non-refundable fee for use of the Augmedix Solution, as determined by (i) the Authorized
User’s Daily Schedule and anticipated monthly Scribe Service hour usage (e.g., up to 100 Scribe Service hours per month), and (ii)
an hourly rate of $[***] per Scribe Service hour (“Base Plan”). Scribe Service hours exceeding an Authorized Users
Base Plan (“Overages”) will be billed at the rate of $[***] per Scribe Service Hour.

 

Augmedix reserves the right to reset
an Authorized User’s Base Plan based upon material changes to the Daily Schedule and/or actual monthly usage upon [***] written
notice to Client. Client may request changes to an Authorized User’s Base Plan due to changes to Daily Schedules and/or anticipated
monthly usage by providing [***] written notice to Augmedix.”

 

3. Fee
Increases. Notwithstanding anything to the contrary in the Dignity SOWs, any increase in Fees shall be mutually agreed upon by
the Parties upon each anniversary of the Amendment Effective Date.

 

4. Invoicing.
Notwithstanding anything to the contrary in the Dignity SOWs, the following shall apply:

 

“Augmedix
will invoice Client on a monthly basis (or pro-rata portions thereof) for Service Fees in advance of each month, and the first month of
Service for first-time Authorized Users in advance of each month. Overages, if any, will be billed monthly in arrears.”

 

5. General.
Capitalized terms used but not otherwise defined herein shall have the same meaning as in the Dignity SOWs and the Agreement. This Second
Omnibus Amendment is hereby incorporated into the Dignity SOWs by reference. Except as expressly amended herein, all other terms of the
Dignity SOWs are hereby confirmed and remain in full force and effect. To the extent that there is any conflict between the terms of this
Second Omnibus Amendment and those of the Agreement or the Dignity SOWs, the terms of this Second Omnibus Amendment shall control. This
Second Omnibus Amendment may be executed in several counterparts, all of which taken together shall constitute one single agreement between
the parties and any full and complete copy thereof shall constitute an original. When signed in pen ink, such documents may be delivered
by facsimile transmission or by scanned email attachment, and said copies shall be treated in all respects as original.

 

    
	Omnibus Amendment	 	
	Augmedix – Dignity Health 	 	Page 1

    

    

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO AUGMEDIX, INC.
IF PUBLICLY DISCLOSED.

 

AGREED AND ACCEPTED

 

	DIGNITY HEALTH	 	AUGMEDIX Operating Corp. F/K/A Augedix Inc.
	 	 	 	 	 
	By	/s/ Kelley Moore	 	By:	/s/ Manny Krakaris
	Name:	Kelley Moore	 	Name:	Manny Krakaris
	Title:	System VP, Vendor Mgmt & Contracting	 	Title: 	CEO
	Date: 	August 11, 2021	 	Date: 	August 11, 2021
	 	 	 	 	 
	DIGNITY HEALTH MEDICAL FOUNDATION	 	 	 
	 	 	 	 	 
	By	/s/ Kelley Moore	 	 	 
	Name: 	Kelley Moore	 	 	 
	Title: 	System VP, Vendor Mgmt & Contracting	 	 	 
	Date: 	August 11, 2021	 	 	 
	 	 	 	 	 
	PACIFIC CENTRAL COAST HEALTH CENTERS	 	 	 
	 	 	 	 	 
	By	/s/ Kelley Moore	 	 	 
	Name: 	Kelley Moore	 	 	 
	Title: 	System VP, Vendor Mgmt & Contracting	 	 	 
	Date: 	August 11, 2021	 	 	 

 

 

	Omnibus Amendment	 	
	Augmedix – Dignity Health 	 	Page 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]